La FDA anuncia planes para aliviar la escasez de fórmula para bebés

Los padres que luchan por encontrar fórmula para bebés pronto podrían encontrar algo de alivio.

Abbott Nutrition, uno de los mayores fabricantes de fórmulas en EE. UU., llegó a un acuerdo con el gobierno para reabrir una de sus fábricas cerradas y aumentar la producción.

Abbott cerró sus instalaciones en Sturgis, Michigan, en febrero después de que varios bebés se enfermaron después de beber fórmula. Dos de ellos murieron por infecciones bacterianas.

The Justice Department filed a complaint against Abbott, alleging the factory failed to comply with quality and safety regulations. Now Abbott and the government have agreed to a proposed settlement to resolve the complaint. It requires a third-party expert at the Michigan facility to help restart production and increase the formula supply safely.

In a written statement, Abbott said production at the facility could restart within two weeks, following FDA approval. It would take another six to eight weeks before formula from the plant would be available on grocery shelves.

In the meantime, the FDA is announcing other plans to ease the nationwide formula shortage. FDA Commissioner Robert Califf acknowledged the struggles many parents are facing.


La FDA prepara un anuncio importante para aliviar la falta de fórmula para bebés

Leave a Reply

Your email address will not be published.